申请人:Max-Planck-Gesellschaft zur Förderung
der Wissenschaften e.V.
公开号:EP2607352A1
公开(公告)日:2013-06-26
The present invention relates to compounds having a pipecolate diketoamide scaffold, pharmaceutically acceptable salts of these compounds and pharmaceutical compositions containing at least one of these compounds together with pharmaceutically acceptable carrier, excipient and/or diluents. Said pipecolate diketoamide compounds can be used for prophylaxis and/or treatment of psychiatric disorders and neurodegenerative diseases, disorders and conditions.
本发明涉及具有吡啶甲酸二酮酰胺骨架的化合物,这些化合物的药用盐以及含有至少一种这些化合物的药物组合物,与药用载体、赋形剂和/或稀释剂一起。所述的吡啶甲酸二酮酰胺化合物可用于预防和/或治疗精神障碍和神经退行性疾病、障碍和症状。